{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:13:33Z","timestamp":1788408813271,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40119-026-00455-7","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:17:59Z","timestamp":1781795879000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Patient and Physician Perspective of Chronic Coronary Syndrome and Persistent Stable Angina in Brazil"],"prefix":"10.1007","volume":"15","author":[{"given":"Ant\u00f4nio Figueiredo","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparecida","family":"de F\u00e1tima Machado Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-7506","authenticated-orcid":false,"given":"Lu\u00eds Henrique Wolff","family":"Gowdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jacasi.2024.12.004","volume":"5","author":"Y Xie","year":"2025","unstructured":"Xie Y, Jiang J, Wang J. Management of chronic coronary syndrome. JACC Asia. 2025;5:327\u201331.","journal-title":"JACC Asia"},{"key":"455_CR2","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","volume":"169","author":"JF Beltrame","year":"2009","unstructured":"Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med. 2009;169:1491\u20139.","journal-title":"Arch Intern Med"},{"key":"455_CR3","doi-asserted-by":"publisher","first-page":"744788","DOI":"10.3389\/fcvm.2021.744788","volume":"8","author":"PK Mehta","year":"2021","unstructured":"Mehta PK, Wei J, Shufelt C, Quesada O, Shaw L, Bairey Merz CN. Gender-related differences in chest pain syndromes in the frontiers in CV medicine special issue: sex & gender in CV medicine. Front Cardiovasc Med. 2021;8:744788.","journal-title":"Front Cardiovasc Med"},{"key":"455_CR4","doi-asserted-by":"publisher","first-page":"e000376","DOI":"10.1136\/openhrt-2015-000376","volume":"3","author":"C Kreatsoulas","year":"2016","unstructured":"Kreatsoulas C, Crea-Arsenio M, Shannon HS, Velianou JL, Giacomini M. Interpreting angina: symptoms along a gender continuum. Open Heart. 2016;3:e000376.","journal-title":"Open Heart"},{"key":"455_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1186\/s12889-025-22214-4","volume":"25","author":"N Mostafa","year":"2025","unstructured":"Mostafa N, Sayed A, Hamed M, Dervis M, Almaadawy O, Baqal O. Gender disparities in delayed angina diagnosis: insights from 2001-2020 NHANES data. BMC Public Health. 2025;25:1197.","journal-title":"BMC Public Health"},{"key":"455_CR6","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415\u2013537.","journal-title":"Eur Heart J"},{"key":"455_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","volume":"81","author":"WE Boden","year":"2023","unstructured":"Boden WE, Marzilli M, Crea F, et al. Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week. J Am Coll Cardiol. 2023;81:505\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"455_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","volume":"16","author":"V Kunadian","year":"2021","unstructured":"Kunadian V, Chieffo A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on coronary pathophysiology & microcirculation en-dorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention. 2021;16:1049\u201369.","journal-title":"EuroIntervention"},{"key":"455_CR9","doi-asserted-by":"publisher","first-page":"101420","DOI":"10.1016\/j.cpcardiol.2022.101420","volume":"48","author":"B Hansen","year":"2023","unstructured":"Hansen B, Holtzman JN, Juszczynski C, et al. Ischemia with no obstructive arteries (INOCA): a review of the prevalence, diagnosis and management. Curr Probl Cardiol. 2023;48:101420.","journal-title":"Curr Probl Cardiol"},{"key":"455_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","volume":"169","author":"M Gulati","year":"2009","unstructured":"Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women\u2019s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169:843\u201350.","journal-title":"Arch Intern Med"},{"key":"455_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCULATIONAHA.122.063466","volume":"147","author":"JM Luu","year":"2023","unstructured":"Luu JM, Malhotra P, Cook-Wiens G, et al. Long-term adverse outcomes in black women with ischemia and no obstructive coronary artery disease: a study of the WISE (Women\u2019s Ischemia Syndrome Evaluation) cohort. Circulation. 2023;147:617\u20139.","journal-title":"Circulation"},{"key":"455_CR12","doi-asserted-by":"publisher","first-page":"e002852","DOI":"10.1136\/openhrt-2024-002852","volume":"11","author":"N Odanovi\u0107","year":"2024","unstructured":"Odanovi\u0107 N, Schwann AN, Zhang Z, et al. Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis. Open Heart. 2024;11:e002852.","journal-title":"Open Heart"},{"key":"455_CR13","doi-asserted-by":"publisher","first-page":"e20250619","DOI":"10.36660\/abc.20250619i","volume":"122","author":"LA Machado Cesar","year":"2025","unstructured":"Machado Cesar LA, Gowdak LHW, Pavanello R, et al. Guideline for chronic coronary syndrome - 2025. Arq Bras Cardiol. 2025;122:e20250619.","journal-title":"Arq Bras Cardiol"},{"key":"455_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/eurheartj\/ehz660","volume":"41","author":"E Sorbets","year":"2020","unstructured":"Sorbets E, Fox KM, Elbez Y, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J. 2020;41:347\u201356.","journal-title":"Eur Heart J"},{"key":"455_CR15","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.jacc.2015.09.020","volume":"66","author":"TD Henry","year":"2015","unstructured":"Henry TD, Gershlick A. Going beyond the hard endpoints: \u201cquality of life\u201d may be dependent on quality of available data. J Am Coll Cardiol. 2015;66:2114\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"455_CR16","doi-asserted-by":"publisher","first-page":"16624","DOI":"10.1161\/circ.148.suppl_1.16624","volume":"148","author":"G Rosano","year":"2023","unstructured":"Rosano G, George M, Kaski J-C, et al. Abstract 16624: patients\u2019 perspectives on the impact and management of angina - preliminary results of the PACT-ANGINA in-ternational survey [AHA abstract]. Circulation. 2023;148:16624.","journal-title":"Circulation"},{"key":"455_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00392-013-0568-z","volume":"102","author":"L Jespersen","year":"2013","unstructured":"Jespersen L, Abildstrom SZ, Hvelplund A, Prescott E. Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris. Clin Res Cardiol. 2013;102:571\u201381.","journal-title":"Clin Res Cardiol"},{"key":"455_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10654-014-9926-z","volume":"29","author":"A Loerbroks","year":"2014","unstructured":"Loerbroks A, Bosch JA, Mommersteeg PM, Herr RM, Angerer P, Li J. The association of depression and angina pectoris across 47 countries: findings from the 2002 World Health Survey. Eur J Epidemiol. 2014;29:507\u201315.","journal-title":"Eur J Epidemiol"},{"key":"455_CR19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9\u2013119.","journal-title":"Circulation"},{"key":"455_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0003319718796313","volume":"70","author":"G Ambrosio","year":"2019","unstructured":"Ambrosio G, Collins P, Dechend R, Lopez-Sendon J, Manolis AJ, Camm AJ. Stable angina: perception of needs, quality of life and management of patients (BRIDGE Study)\u2014a multinational European physician survey. Angiology. 2019;70:397\u2013406.","journal-title":"Angiology"},{"key":"455_CR21","doi-asserted-by":"publisher","first-page":"e037909","DOI":"10.1161\/JAHA.124.037909","volume":"14","author":"A Hausvater","year":"2025","unstructured":"Hausvater A, Anthopolos R, Seltzer A, et al. Sex differences in psychosocial factors and angina in patients with chronic coronary disease. J Am Heart Assoc. 2025;14:e037909.","journal-title":"J Am Heart Assoc"},{"key":"455_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40119-025-00405-9","volume":"14","author":"LHW Gowdak","year":"2025","unstructured":"Gowdak LHW, Dourado PMM, Pr\u00e9coma DB, et al. Effectiveness and tolerability of trimetazidine 80\u00a0mg once daily in patients with chronic coronary syndrome in Brazil: the V-GOOD observational study. Cardiol Ther. 2025;14:249\u201365.","journal-title":"Cardiol Ther"},{"key":"455_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000332369","volume":"120","author":"N Danchin","year":"2011","unstructured":"Danchin N, Marzilli M, Parkhomenko A, Ribeiro JP. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011;120:59\u201372.","journal-title":"Cardiology"},{"key":"455_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ijcard.2014.10.149","volume":"177","author":"S Peng","year":"2014","unstructured":"Peng S, Zhao M, Wan J, Fang Q, Fang D, Li K. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. Int J Cardiol. 2014;177:780\u20135.","journal-title":"Int J Cardiol"},{"key":"455_CR25","first-page":"353","volume":"4","author":"J Kempf","year":"2011","unstructured":"Kempf J, Buysman E, Brixner D. Health resource utilization and direct costs associated with angina for patients with coronary artery disease in a US managed care setting. Am Health Drug Benefits. 2011;4:353\u201361.","journal-title":"Am Health Drug Benefits"},{"key":"455_CR26","first-page":"S358","volume":"10","author":"HS Javitz","year":"2004","unstructured":"Javitz HS, Ward MM, Watson JB, Jaana M. Cost of illness of chronic angina. Am J Manag Care. 2004;10:S358\u201369.","journal-title":"Am J Manag Care"},{"key":"455_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/heart.89.8.848","volume":"89","author":"S Stewart","year":"2003","unstructured":"Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. The current cost of angina pectoris to the National Health Service in the UK. Heart. 2003;89:848\u201353.","journal-title":"Heart"},{"key":"455_CR28","first-page":"39","volume":"109","author":"A de S\u00e1 Earp Siqueira","year":"2017","unstructured":"de S\u00e1 Earp Siqueira A, Gon\u00e7alves de Siqueira-Filho A, Land MGP. Analysis of the economic impact of cardiovascular diseases in the last five years in Brazil. Arq Bras Cardiol. 2017;109:39\u201346.","journal-title":"Arq Bras Cardiol"},{"key":"455_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s12325-017-0490-2","volume":"34","author":"M Glezer","year":"2017","unstructured":"Glezer M. Real-world evidence for the antianginal efficacy of trimetazidine from the Russian observational CHOICE-2 study. Adv Ther. 2017;34:915\u201324.","journal-title":"Adv Ther"},{"key":"455_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12325-018-0674-4","volume":"35","author":"M Glezer","year":"2018","unstructured":"Glezer M. The effectiveness of trimetazidine treatment in patients with stable angina pectoris of various durations: results from the CHOICE-2 study. Adv Ther. 2018;35:1103\u201313.","journal-title":"Adv Ther"},{"key":"455_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1157\/13072496","volume":"205","author":"L Rodr\u00edguez Padial","year":"2005","unstructured":"Rodr\u00edguez Padial L, Maicas Bellido C, Vel\u00e1zquez Mart\u00edn M, Gil Polo B. A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study. Rev Clin Esp. 2005;205:57\u201362 (in Spanish).","journal-title":"Rev Clin Esp"},{"key":"455_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40119-020-00174-7","volume":"9","author":"MG Glezer","year":"2020","unstructured":"Glezer MG, Vygodin VA, ODA investigators. Effectiveness of trimetazidine in patients with stable angina pectoris of various durations: results from ODA. Cardiol Ther. 2020;9:395\u2013408.","journal-title":"Cardiol Ther"},{"key":"455_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.134050","volume":"v","author":"M Marzilli","year":"2026","unstructured":"Marzilli M, Gowdak LHW, Sobhy M, Mittal S, Bakar RA, Stoicescu C; COMBINE Angina investigators. Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study. Int J Cardiol. 2026;446:134050.","journal-title":"Int J Cardiol"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-026-00455-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:23:57Z","timestamp":1788405837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-026-00455-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1007\/s40119-026-00455-7","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lu\u00eds Henrique Wolff Gowdak has received payments or honoraria from Servier and Novartis, support for attending meetings and\/or travel from Servier, and has served on a data safety monitoring board and advisory board for Servier. Ant\u00f4nio Figueiredo Ara\u00fajo and Aparecida de F\u00e1tima Machado Tavares have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on the experience of the authors (two patients and a physician) and literature from previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The patients have consented to publication of this report.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}